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Introduction
Calculous disease of the biliary tract is common. Clinically,
patients may present with symptoms or complications related
to stones in the gallbladder or bile ducts. Cholesterol stones
account for most stones encountered in patients in the West-
ern hemisphere, whereas black and brown pigment stones are
encountered frequently among patients in the Far East.1 Ul-
trasonography is more than 95% effective for the diagnosis of
cholelithiasis, but it is insensitive for the diagnosis of choledo-
cholithiasis.2 Therefore, common bile duct stones (CBDS)
have traditionally been identified by direct contrast radiogra-
phy through endoscopic, percutaneous or operative approaches.
In more than 90% of patients with choledocholithiasis, the
process develops due to stone passage from the gallbladder
into the extrahepatic biliary tract (secondary choledocho-
lithiasis),1 so management generally requires the removal of
a gallbladder with CBDS. Choledocholithiasis is discovered
in 8% to 20% of patients undergoing cholecystectomy, with
most patients having clinical, biochemical or sonographic
abnormalities suggestive of CBDS.3–5 During the era of open
cholecystectomy, preoperative indicators were frequently
used to select patients for cholangiography. When selected,
patients underwent intraoperative cholangiography (IOC),
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where CBDS may be identified and treated during the same
operation.
Following the introduction of laparoscopic cholecystec-
tomy (LC), several treatment options have emerged for the
management of patients with gallbladder disease and sus-
pected choledocholithiasis. The “one-step” approach involves
LC, intraoperative diagnosis and laparoscopic management
of CBDS. The “two-step” approach frequently relies on the
preoperative diagnosis and treatment of CBDS prior to LC
or, alternatively, CBDS are identified during LC and treated
postoperatively by endoscopic sphincterotomy (ES). Although
the “one-step” approach is an effective and safe option for
many patients,6,7 it has not gained wide acceptance among
surgeons for various reasons. The debate regarding the opti-
mal treatment approach for patients with CBDS is ongoing,
unresolved, and beyond the scope of the current review.
As many surgeons continue to approach patients with
gallbladder disease by attempting to identify and treat CBDS
prior to LC, endoscopic retrograde cholangiography (ERC)
has remained the most commonly applied technique for the
preoperative detection of CBDS, and ES is commonly applied
during ERC to facilitate CBDS removal.3 Although ERC is
effective for the diagnosis of choledocholithiasis, the proce-
dure is invasive and has been reported to be associated with
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complications in approximately 3% of all cases.8 As some
surgeons continue to apply traditional indicators to select
patients for preoperative imaging by ERC, in some practices
30% to 70% of patients undergoing this procedure have
no CBDS identified.3 Concerns with the morbidity and
costs associated with ERC have led to the development of
alternative imaging methodologies for biliary tract evalua-
tions. Table 1 lists the available biliary imaging modalities and
Table 23,9–42 lists the diagnostic efficacies, advantages and
disadvantages of each. Magnetic resonance cholangiography
(MRC) is one of the newer imaging tools that have emerged as
potential diagnostic tools to replace ERC.35,43 This review
summarizes the clinical experience with MRC and discusses
its status in the management of patients with calculous dis-
ease of the biliary tract.
Techniques and limitations
MRC applies a heavily T2-weighted pulse sequence to delin-
eate biliary tract anatomy and pathology. With this technique,
the relatively static fluid within the biliary and pancreatic
ducts appears as a white, rapidly flowing fluid, and back-
ground tissue appears hypodense; solid structures such as
stones produce localized signal voids and appear black (Figure
1). Either a single breath-hold technique or a non-breath-hold
technique may be used for image acquisition. Some radio-
Table 1. Available biliary imaging modalities
Non-invasive
   Transabdominal ultrasonography
   Magnetic resonance cholangiography
   Computed tomography cholangiography
Invasive
   Intravenous cholangiography
   Endoscopic ultrasonography
   Endoscopic retrograde cholangiography
   Percutaneous transhepatic cholangiography
Operative
   Laparoscopic ultrasonography
   Intraoperative cholangiography
   Intraoperative choledochoscopy
graphers favour the breath-hold technique, citing association
with fewer motion artifacts. The non-breath-hold technique
may offer advantages for patients who may be uncooperative
or unable to follow verbal instructions. MRC is generally well
tolerated by patients,44 and the procedure may be completed
in approximately 10 to 15 minutes without exposure to ioniz-
ing radiation or the application of sedatives or contrast mate-
rial. Due to the small, enclosed space of the MR scanner, pa-
tients may be deemed unsuitable for this examination because
of large body habitus or claustrophobia. Several patient fac-
Figure 1. Magnetic resonance cholangiography (MRC). Coronal and axial MRC views demonstrating the presence of a 3 mm common bile
duct stone in the distal common bile duct.
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Table 2. Efficacy of biliary imaging modalities
Method
            Diagnostic efficacy for CBDS
Advantages Disadvantages
         Sensitivity, %      Specificity, %
ERC9–11 95–100 (mean, 98) 95–100 (mean, 98) Therapeutic capabilities; Requires sedation/
identifies anatomy and analgesia; patient
anomalies discomfort; complications
MRC12–31 57–100 (mean, 90) 73–100 (mean, 96) Non-invasive; reproducible; No therapeutic capability
identifies anatomy and
anomalies
Transabdominal 20–38 80–100 Identifies cholelithiasis in Limited sensitivity for CBDS
US24,25,32 95% of patients; easy to
interpret
CT23,33,34 Unenhanced CT: 65–90 80–85 Widely available; Expertise required in the inter-
CT/oral contrast: 90–96 95 non-invasive pretation of unenhanced CT
Endoscopic 75–98 (mean, 95) 90–100 Equipment and expertise Requires sedation/
US3,18,23,35 (mean, 96) required analgesia; may miss stones
in hepatic ducts
Intravenous cho- 88–93 97–99 Identifies anatomy and Adverse reactions reported
langiography36–38 anatomical variants in 0–12% of patients, with
severe reactions reported in
0–9% of patients; not FDA
approved in the USA
IOC23,31,36 75–100 (mean, 90) 75–100 (mean: 95) Identifies anatomy and
(reduced with static anatomical variants;
cholangiography) special skills and
equipment not needed
Laparoscopic 90–100 (mean, 95) 98–100 (mean, 99) More sensitive than ERC Requires special equipment
US39–41 and MRC at identifying and expertise
CBDS < 3 mm; may be
repeated during the
operation
Laparoscopic cho- Success rate, %: 67–100 Therapeutic Requires expertise and
ledochoscopy42 (mean, 91) capabilities equipment; may cause
pancreatitis, bleeding
and perforation
CBDS = common bile duct stones; ERC = endoscopic retrograde cholangiography; MRC = magnetic resonance cholangiography; US =
ultrasonography; CT = computed tomography; IOC = intraoperative cholangiography; FDA = Food and Drug Administration.
tors have been shown to affect MRC accuracy; for example, the
presence of ascites, periductal inflammation, periampullary
duodenal diverticulum and crossing blood vessels may ob-
scure the ductal fluid signal and lead to inadequate visualiza-
tion of the distal CBD.45 False-positive findings have been
reported to occur as the result of a prominent sphincter of
Oddi, duct tortuosity, cystic duct insertion, pneumobilia and
surgical clips.45 Additionally, radiographer inexperience con-
tributes to inadequate application of image angles during
image acquisition, resulting in the non-visualization of small
CBDS.45 Once obtained, the interpretation of MRC images by
independent observers is consistent and reproducible.12
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MRC accuracy
We are not aware of any randomized prospective studies pub-
lished to date evaluating MRC accuracy and utility. However,
between 1995 and 2002, numerous case control series were
published comparing the diagnostic characteristics of MRC to
standard imaging.12–31 Cumulatively, these investigations have
reported MRC sensitivity of 90% (57–100%) and specificity of
Table 3. Results of magnetic resonance cholangiography (MRC) for the detection of choledocholithiasis
Source n     Study      Patient       CBDS  Comparison Sensitivity/specificity/
    design      disease prevalence, %        study         accuracy, %
Reinhold et al12 110 Prospective Stones 27 ERC and IOC 90/100/97
Stiris et al13 50 Prospective Mixed disease 56 ERC 88/94/90
population
Mendler et al14 58 Prospective Mixed disease 58 ERC 86/97/91
population
Laokpessi, et al15 147 Prospective Stones 76 ERC and IOC 93/100
Magnuson et al16 143 Prospective Mixed disease 49 ERC and PTC 92/99
population
Liu et al17 99 Prospective Stones 30 ERC and IOC 85/90/89
Soto et al18 49 Prospective Stones 49 ERC 92–100/92–100
(Interpretations correlated
between observers)
Scheiman et al19 30 Prospective Stones and 17 ERC and EUS 40/96
stricture
Holzknecht et al20 61 Prospective Stones and 40 ERC 93/96
stricture
Zidi et al21 70 Prospective Mixed disease 70 ERC and IOC 57/100
population
Lomas et al22 69 Prospective Mixed disease 13 ERC 100/97
population
Soto et al23 51 Prospective Stones 51 ERC and CT cho- 96/100
langiography
Varghese et al24 100 Prospective Mixed disease 30 ERC, PTC, and 93/99/97
population IOC
Varghese et al25 191 Prospective Mixed disease 18 ERC, PTC, US, 91/98/97
population and IOC
Chan et al26 47 Prospective Stones 42 ERC 95/95/89
Demartines et al27 70 Prospective Stones 52 ERC and IOC 100/96
Sugiyama et al28 97 Retrospective Stones 35 ERC and US 91/100/97
Guibaud et al29 126 Retrospective Mixed disease 25 ERC, PTC, and 81/98/94
population IOC
Fulcher et al30 265 Retrospective Mixed disease 5 ERC, PTC, and 100/100/100
population IOC
Calvo et al31 116 Prospective Stones 29 ERC 91/90
CBDS = common bile duct stones; ERC = endoscopic retrograde cholangiopancreatography; IOC = intraoperative cholangiography;
PTC = percutaneous transhepatic cholangiography; EUS = endoscopic ultrasound; CT = computed tomography; US = ultrasonography.
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96% (73–100%) for CBDS detection. Table 312–31 summarizes
the findings from the major series. In these reports, the mini-
mal resolution of MRC for CBDS was in the range of 2 to 3 mm.
However, one group has reported decreased sensitivity of
MRC in identifying CBDS of less than 6 mm in diameter.21
Generally, the reported MRC accuracy for CBDS is compara-
ble with the accuracies reported for ERC and IOC. MRC has
been shown to possess superior diagnostic accuracy for visu-
alization of intrahepatic stones when compared to ERC.46
Applications prior to LC
The concept of being able to rapidly and non-invasively image
the biliary tract prior to LC is appealing to patients and
physicians who may prefer to identify and treat CBDS prior to
LC. Therefore, preoperative patients represent the most exten-
sively investigated patient population to date. When applied
in this setting, MRC accurately visualized CBDS in selected
patients who were thought to benefit from preoperative endo-
scopic stone extraction.15,17,27 Similarly, MRC identified pa-
tients without choledocholithiasis, eliminating unnecessary
ERC in these individuals. These initial experiences have led
some physicians to conclude that MRC is a valuable diagnostic
tool in this patient population.15–17,27 While recognizing these
advantages of MRC, most investigators agree that MRC is
unnecessary and inappropriate in the management of patients
for whom there is high suspicion of choledocholithiasis, such
as those with cholangitis or severe jaundice.17,27,31,47 At the
same time, some physicians believe that the liberal application
of preoperative MRC in patients with low clinical suspicion for
choledocholithiasis may contribute to delays and unnecessary
expenses in patient management.17 The initial results have
prompted some physicians to question the value of MRC in
patient management.48
The cost effectiveness of various diagnostic options for
patients with biliary pancreatitis was the focus of an investiga-
tion by Arguedas et al.49 By applying a decision-tree analysis
model, these investigators determined that ERC was the most
cost-effective initial study when applied to patients with more
than 58% probability of having CBDS, while observation and
IOC were the most cost-effective strategies for patients with
less than 15% probability of having choledocholithiasis. For
patients with moderate probability of having CBDS (15–58%),
either MRC or endoscopic ultrasonography was the most cost-
effective initial diagnostic strategy.49
As data from mathematical modelling have indicated that
patients with a moderate risk of having choledocholithiasis
are the most appropriate patients to undergo initial imaging
with MRC, there have been limited clinical data published to
specifically guide patient selection for MRC prior to LC. In
the study by Liu et al, patients were identified and triaged
preoperatively into four categories based on the probability of
choledocholithiasis.47 Patients with high probability were
directed to ERC/ES prior to LC. Moderate-probability pa-
tients were directed to MRC and subsequent ERC/ES when
CBDS were visualized. Low-probability patients were directed
Table 4. Designation of choledocholithiasis probability
Probability of CBDS Clinical diagnosis Ultrasonography results Serum chemistry results
High Absence of cholecystitis CBD diameter ≥ 5 mm Presence of ≥ 2 indicators: total bilirubin ≥
or pancreatitis 1.5 mg/dL; alkaline phosphatase ≥ 150 U/L;
AST ≥ 100 U/L; ALT ≥ 100 U/L
Moderate Presence of pancreatitis, CBD diameter ≥ 5 mm Presence of ≥ 2 indicators: total bilirubin ≥
cholecystitis, or resolving 1.5 mg/dL; alkaline phosphatase ≥ 150 U/L;
choledocholithiasis AST ≥ 100 U/L; ALT ≥ 100 U/L
Low Any diagnosis CBD < 5 mm Presence of ≥ 2 indicators: total bilirubin ≥
1.5 mg/dL; alkaline phosphatase ≥ 150 U/L;
AST ≥ 100 U/L; ALT ≥ 100 U/L
Very low No evidence of jaundice, CBD < 5 mm Total bilirubin < 1.5 mg/dL; alkaline
cholangitis, or pancreatitis phosphatase < 150 U/L; AST < 100 U/L;
ALT < 100 U/L
CBDS = common bile duct stones; CBD = common bile duct; AST = aspartate transaminase; ALT = alanine transaminase. Adapted with
permission from reference 46.
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to LC with IOC, and very low-probability patients underwent
LC without any imaging. These patient assignment criteria
and the triage scheme are depicted in Table 4 and Figure 2.
Prospective application of this treatment algorithm resulted
in finding choledocholithiasis in 92.6%, 32.4%, 3.8% and 0.9%
of patients in the four groups, respectively. With this triage
scheme, 95% of patients who underwent ERC had CBDS
identified, and unexpected CBDS were found in 1.4% of all
patients. MRC use was limited to 8.4% of the patients, repre-
senting a significant reduction from the 23.5% application in
patients treated during the time period immediately prior to
the study. Based on the findings from this study, it appears
that stratification of CBDS risk improves resource utilization.
However, additional research is needed to further improve
patient management and define the roles of ERC and MRC in
the perioperative setting.
Applications after LC
Considerations of bile leak, retained CBDS and bile duct
injury are the usual indications leading to imaging of bile
ducts in the postoperative setting. While there is less experi-
ence with MRC application in patients following LC, this
approach possesses similar diagnostic accuracy for chole-
docholithiasis as in the preoperative setting. MRC accurately
identifies and helps to characterize cystic duct leak, bile duct
strictures and major bile duct injuries in the postoperative
setting.50–53 The selection of an imaging modality in this
setting should take into consideration the degree of suspicion
for complications and the patient’s intended treatment plan.
When the clinical suspicion for complications is high and the
problem is amenable to non-operative management, ERC or
percutaneous transhepatic cholangiography should be con-
sidered initially to avoid unnecessary delays in therapy. MRC
may be considered when patients with low to moderate sus-
picion of having biliary complications are encountered, where
initial MRC imaging may prevent the use of unnecessary
invasive procedures. Similarly, MRC may be useful for pre-
operative evaluation of selected patients with biliary tract
injuries requiring operative reconstruction. Based on our re-
view of published results, there are no available data to help
identify patients who may benefit from MRC evaluation in
this setting.
Evaluation of primary CBDS
Primary CBDS form de novo in the bile ducts and these are
generally calcium bilirubinate stones.1 The formation of pri-
mary CBDS is generally due to the combined effects of bacte-
rial overgrowth and biliary stasis. Calcium bilirubinate stones
Figure 2. Selective imaging strategy based on the probability of choledocholithiasis. LC = laparoscopic cholecystectomy; ERC = endoscopic
retrograde cholangiopancreatography; ES = endoscopic sphincterotomy; MRC = magnetic resonance cholangiography; IOC = intraoperative
cholangiography; CBDS = common bile duct stones. Adapted with permission from reference 46.
Patient with gallstone disease,
LC considered
Clinical, laboratory, and ultrasonographic evaluation
High probability Moderate probability Low probability Very low probability
ERC/ES MRC LC/IOC LC
                   CBDS clearance (– CBDS)      (+ CBDS) (+ CBDS)
    LC ERC/ES  ERC/ES
CBDS clearance
LC
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have greater fluidity than cholesterol stones; therefore, pri-
mary stones are generally associated with a lesser degree of
signal void and may appear less distinct than cholesterol
stones on MRC.26,54 Chan et al in Hong Kong retrospectively
assessed the accuracy of T2-weighted MRC and reported a
sensitivity of 87% for primary CBDS identification.54 This
high accuracy was achieved despite the mixed signal intensity
found in 21% of stones in these patients. This group subse-
quently conducted a prospective evaluation of MRC accuracy
for CBDS identification, in which MRC was found to possess
sensitivity of 95% and specificity of 85% for CBDS identifica-
tion when compared to ERC findings.26 During this study,
pneumobilia was recognized as a cause of false-positive re-
sults. These results suggest that MRC is accurate and may be
useful for preoperative imaging in selected patients with pri-
mary CBDS.
The reported rate of recurrent CBDS following ERC ranges
from 4% to 10%.54–57 Several risk factors for recurrence have
been reported, including a CBD diameter of more than 20 mm,
pneumobilia, and the presence of periampullary diverticu-
lum.54–57 It has been suggested that regular surveillance ERCP
is useful for early identification of recurrent CBDS and in
preventing the development of cholangitis.56,57 Although the
effectiveness of surveillance MRC has not been evaluated
specifically, it would appear that this modality would be highly
useful for long-term follow-up in these patients.
Summary
The diagnostic capabilities of MRC have undergone rigorous
evaluations and these investigations have generally confirmed
that MRC possesses diagnostic accuracies that are similar to
those of direct cholangiography. MRC provides a safe, effec-
tive and non-invasive method to identify CBDS. The availabil-
ity of MRC has made a dramatic impact on the management
of patients with suspected choledocholithiasis in whom
preoperative treatment of CBDS is contemplated. There is
general agreement that MRC reduces and may eliminate the
need for diagnostic ERC and it may reduce the occurrence of
ERC-related morbidity. Clinical evidence suggests that MRC
may be most beneficial and cost-effective when applied to
patients with a moderate probability of having choledocho-
lithiasis, but there are limited clinical data available to guide
patient selection. Future investigations should be directed
toward the development of safe and efficient MRC application
strategies that are consistent with the goals and objectives of
a minimally invasive approach to patient care.
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